Results of the PROPINE randomized controlled study suggest tapering of prednisone treatment for relapses of steroid sensitive nephrotic syndrome is not necessary in children.
Gargiulo A, Massella L, Ruggiero B, Ravà L, Ciofi Degli Atti M, Materassi M, Lugani F, Benetti E, Morello W, Molino D, Mattozzi F, Pennesi M, Maringhini S, Pasini A, Gianoglio B, Pecoraro C, Montini G, Murer L, Ghiggeri GM, Romagnani P, Vivarelli M, Emma F.
Gargiulo A, et al. Among authors: lugani f.
Kidney Int. 2021 Feb;99(2):475-483. doi: 10.1016/j.kint.2020.09.024. Epub 2020 Nov 2.
Kidney Int. 2021.
PMID: 33152448
Clinical Trial.